According to a press release by law firm Hagens Berman, a group of purchasers believes Mylan "engaged in an illegal organized scheme to systematically increase EpiPen prices by 574 percent."
The complaint states that since Mylan secured the rights to distribute the life-saving drug in 2007, it increased prices 17 times from $90.28 to $608.62.
“Mylan has tried every trick in the book to avoid taking accountability for the millions of people who are living without the EpiPen they need to prevent a life-threatening allergic reaction," Steve Berman stated.
More
4 comments:
this is the best news ever!
people are tired of being screwed
LOL! The only people that get paid in a class action are the lawyers on both sides. Consumers get pennies on the dollar.
Thieves.
The main point isn't to get damages for the users, it's to lower the price to something reasonable.
Post a Comment